Related Experiment Video
Updated: Sep 23, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Radiosensitization to γ-Ray by Functional Inhibition of APOBEC3G
Ying Tong1, Sota Kikuhara2,3, Takae Onodera1,2
1Department of Molecular and Genomic Biomedicine, Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
Abstract:
The radiosensitization of tumor cells is one of the promising approaches for enhancing radiation damage to cancer cells and limiting radiation effects on normal tissue. In this study, we performed a comprehensive screening of radiosensitization targets in human lung cancer cell line A549 using an shRNA library and identified apolipoprotein B mRNA editing enzyme catalytic subunit 3G (APOBEC3G: A3G) as a candidate target. APOBEC3G is an innate restriction factor that inhibits HIV-1 infection as a cytidine deaminase. APOBEC3G knockdown with siRNA showed an increased radiosensitivity in several cancer cell lines, including pancreatic cancer MIAPaCa2 cells and lung cancer A549 cells. Cell cycle analysis revealed that APOBEC3G knockdown increased S-phase arrest in MIAPaCa2 and G2/M arrest in A549 cells after γ-irradiation. DNA double-strand break marker γH2AX level was increased in APOBEC3G-knocked-down MIAPaCa2 cells after γ-irradiation. Using a xenograft model of A549 in mice, enhanced radiosensitivity by a combination of X-ray irradiation and APOBEC3G knockdown was observed. These results suggest that the functional inhibition of APOBEC3G sensitizes cancer cells to radiation by attenuating the activation of the DNA repair pathway, suggesting that APOBEC3G could be useful as a target for the radiosensitization of cancer therapy.
Insights
Inhibiting apolipoprotein B mRNA editing enzyme catalytic subunit 3G (APOBEC3G) enhances cancer cell radiosensitivity. This discovery suggests APOBEC3G as a potential target for improving cancer radiation therapy outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Radiosensitization enhances radiation damage to tumor cells while sparing normal tissues.
- Identifying novel targets for radiosensitization is crucial for improving cancer therapy.
Purpose of the Study:
- To screen for radiosensitization targets in human lung cancer cells.
- To investigate the role of apolipoprotein B mRNA editing enzyme catalytic subunit 3G (APOBEC3G) in cancer radiosensitivity.
Main Methods:
- Comprehensive screening using an shRNA library in A549 lung cancer cells.
- APOBEC3G knockdown using siRNA in various cancer cell lines (A549, MIAPaCa2).
- Cell cycle analysis, DNA double-strand break assessment (γH2AX), and in vivo xenograft studies.
Main Results:
- APOBEC3G was identified as a radiosensitization target.
- APOBEC3G knockdown increased radiosensitivity in A549 and MIAPaCa2 cells.
- Knockdown induced cell cycle arrest and increased DNA damage markers post-irradiation; xenograft studies confirmed enhanced radiosensitivity.
Conclusions:
- Functional inhibition of APOBEC3G sensitizes cancer cells to radiation.
- APOBEC3G attenuation of DNA repair pathways contributes to radiosensitization.
- APOBEC3G represents a promising therapeutic target for radiosensitization in cancer treatment.
More Related Videos
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
Related Concept Videos
GPCR Desensitization
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Biological Effects of Radiation
Abnormal Proliferation